SCHEMBL14599045

SCHEMBL14599045

COc1ccc(OC(=O)N(Cc2ccc(O)cc2)C(C)C)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSEN1 P49768 1/20 0.51
▸ PSEN2 P49810 1/20 0.51
▸ APH1B Q8WW43 1/20 0.51
▸ NCSTN Q92542 1/20 0.51
▸ APH1A Q96BI3 1/20 0.51
▸ PSENEN Q9NZ42 1/20 0.51
▸ TAS2R14 Q9NYV8 2/20 0.49
▸ CALM1 P0DP23 1/20 0.46
▸ APLNR P35414 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ HTT P42858 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ PPARG P37231 1/20 0.42
▸ PPARA Q07869 1/20 0.42
▸ TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5422779 0.83 TAS2R14 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL14599044 0.80 MEN1 (0.60) TAS2R14CALM1SMN1; SMN2NPC1MAPT
SCHEMBL13721783 0.77 PPARA (0.51) TAS2R14CALM1SMN1; SMN2NPC1MAPT
SCHEMBL13899483 0.77 MEN1 (0.47) CALM1SMN1; SMN2MAPTGAAPKM
SCHEMBL9781284 0.75 PSEN1 (0.51) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL13720973 0.74 ALOX5 (0.41) CALM1SMN1; SMN2NPC1MAPTRAB9A
SCHEMBL20207280 0.72 APLNR (0.84) TAS2R14CALM1APLNRGAAPKM
SCHEMBL10548133 0.71 PSEN1 (0.53) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL13893855 0.71 KMT2A (0.68) CALM1SMN1; SMN2NPC1MAPTRAB9A
SCHEMBL13721776 0.71 ALOX15 (0.42) NPC1MAPTHTTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070015797-A1 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method CHENG PETER T 2007-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015797-A1 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method GPR119, LIPC, ACACA PSEN1 4789/4885PSEN2 4627/4885APH1B 3747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback